2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by AGARWAL, R. Articles by BRATER, D. C. Search for Related Content PubMed PubMed Citation Articles by AGARWAL, R. Articles by BRATER, D. C.

Urinary Protein Binding Does Not Affect Response to Furosemide in Patients with Nephrotic Syndrome

Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.

Correspondence to Dr. D. Craig Brater, Indiana University School of Medicine, 545 Barnhill Drive, Emerson Hall 317, Indianapolis, IN 46202-5124. Phone: 317-274-8438; Fax: 317-274-1437; E-mail: dbrater{at}iupui.edu

Abstract. Response to loop diuretics in patients with nephrotic syndrome (NS) is subnormal. Studies in animal models of NS have suggested that binding of diuretic to urinary albumin is one of the mechanisms that may be operative in this diuretic resistance. To explore this hypothesis, 12 patients with NS were studied to determine whether displacement from urinary protein binding with sulfisoxazole would restore response to 120 mg of furosemide. The study was stopped after treating seven patients because it was clear that sulfizoxazole had no effect. Sodium excretion (mean ± SD) from furosemide alone was 239 ± 90 versus 240 ± 115 mEq/8 h with sulfisoxazole. Sulfisoxazole had modest effects on serum pharmacokinetics of furosemide but had no effect on either the time course of furosemide urinary excretion or overall amount excreted: 49 ± 15 mg versus 54 ± 12 mg for furosemide alone and furosemide plus sulfisoxazole, respectively. It is concluded that urinary protein binding of loop diuretics is not a major mechanism for the diuretic resistance of NS. In turn, strategies aimed at displacing such binding are unlikely to be clinically helpful.

This article has been cited by other articles:

				N. Takamura, T. Maruyama, E. Chosa, K. Kawai, Y. Tsutsumi, Y. Uryu, K. Yamasaki, T. Deguchi, and M. Otagiri BUCOLOME, A POTENT BINDING INHIBITOR FOR FUROSEMIDE, ALTERS THE PHARMACOKINETICS AND DIURETIC EFFECT OF FUROSEMIDE: POTENTIAL FOR USE OF BUCOLOME TO RESTORE DIURETIC RESPONSE IN NEPHROTIC SYNDROME Drug Metab. Dispos., April 1, 2005; 33(4): 596 - 602. [Abstract] [Full Text] [PDF]

				R. J Elwell, A. P Spencer, and G. Eisele Combined Furosemide and Human Albumin Treatment for Diuretic-Resistant Edema Ann. Pharmacother., May 1, 2003; 37(5): 695 - 700. [Abstract] [Full Text] [PDF]

				S. S. Shankar and D. C. Brater Loop diuretics: from the Na-K-2Cl transporter to clinical use Am J Physiol Renal Physiol, January 1, 2003; 284(1): F11 - F21. [Abstract] [Full Text] [PDF]

				C. S. Wilcox New Insights into Diuretic Use in Patients with Chronic Renal Disease J. Am. Soc. Nephrol., March 1, 2002; 13(3): 798 - 805. [Abstract] [Full Text] [PDF]

				G. DESCHÊNES, M. WITTNER, A. D. STEFANO, S. JOUNIER, and A. DOUCET Collecting Duct Is a Site of Sodium Retention in PAN Nephrosis: A Rationale for Amiloride Therapy J. Am. Soc. Nephrol., March 1, 2001; 12(3): 598 - 601. [Abstract] [Full Text]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673